FRM
WVE icon

Fox Run Management’s Wave Life Sciences WVE Stock Holding History

Fox Run Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
+57,901
New +$384K 0.06% 629
2025
Q4 		– Sell
-41,988
Closed -$307K – 1310
2025
Q3 		$307K Buy
+41,988
New +$340K 0.05% 671
2024
Q1 		– Sell
-20,053
Closed -$101K – 1100
2023
Q4 		$101K Buy
+20,053
New +$107K 0.03% 680

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Fox Run Management's WVE Position: Q2 2026 in Review

Fox Run Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 57,901 shares worth $336K. The stake represents 0.06% of the portfolio and ranks #629 among its holdings. This is a return to the name: Fox Run Management previously reported a position in WVE as recently as Q3 2025.

Fox Run Management first reported a position in WVE in Q4 2023 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Fox Run Management held 57,901 shares of Wave Life Sciences worth $336K as of Q2 2026.
  • Wave Life Sciences was a new Fox Run Management position in Q2 2026.
  • Wave Life Sciences made up 0.06% of Fox Run Management's portfolio in Q2 2026, its #629 holding.
  • Fox Run Management first reported a position in Wave Life Sciences in Q4 2023 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.